Male Hypogonadism: How Stigma and Identity relate to Quality of Life
Official title: The Impact of Anticipated Illness Stigma and Illness Identity on Quality of Life in Men With Hypogonadism: A Comparative Study With Other Chronic Endocrine Diseases
Run by Hacettepe University · NCT07752511 · Data updated 2026-11-12
This study tests whether men with hypogonadism feel more anticipated stigma and have a different illness identity compared with men with other chronic endocrine conditions, and whether those psychosocial factors predict quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Men only |
| Enrollment | 90 (estimated) |
| Sponsor | Hacettepe University Academic / other |
| Locations | 2 sites (Bingoel and 1 other locations) |
| Status | Recruiting |
| Started | October 20, 2026 |
| Main results expected | October 20, 2027 |
| Study ends | October 30, 2027 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT07752511 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Men 18 years or older with biochemically confirmed hypogonadism, and age‑matched men with diabetes, hypertension, or hypothyroidism as controls, all under endocrinology care and fluent in Turkish.
✕Probably not a fit
Results may be less informative for individuals without clinically confirmed hypogonadism or those not fluent in Turkish.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study compares levels of anticipated illness stigma and illness identity in men with hypogonadism to age‑matched men with other chronic endocrine diseases seen in the same clinic. It also explores whether these psychosocial factors predict quality‑of‑life changes within the hypogonadism group. Participants are adult men, with cases having biochemically confirmed hypogonadism and controls having diabetes, hypertension, or hypothyroidism, all under endocrinology care. Inclusion requires Turkish literacy and informed consent; exclusion criteria include active psychiatric illness and certain inflammatory or rheumatic diseases. The study is led by Hacettepe University with collaboration from Turkish clinical sites in Bingöl and Malatya.
Why it matters
Potential benefit: Findings could illuminate psychosocial targets to improve quality of life for men with hypogonadism.
How similar studies have gone: Previous work has explored stigma and illness identity in chronic conditions, but this specific comparison in hypogonadism is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Cases: * Male, aged 18 years or older. * Biochemically confirmed hypogonadism (total testosterone \< 300 ng/dL with at least one clinical symptom). * Regular follow-up at the endocrinology outpatient clinic. * Fluent in reading and understanding Turkish. * Signed informed consent. Controls: * Male, aged 18 years or older. * Diagnosed with diabetes, hypertension, or hypothyroidism under regular endocrinology follow-up. * Total testosterone ≥ 300 ng/dL. * Age-matched to a participant in the case group (±5 years). * Fluent in reading and understanding Turkish. * Signed informed consent. Exclusion Criteria: * Active psychiatric diagnosis (e.g., active psychosis, bipolar disorder). * Chronic inflammatory or rheumatological diseases affecting body composition (e.g., chronic kidney disease, IBD, rheumatoid arthritis, SLE, ankylosing spondylitis). * Uncontrolled co-existing endocrine conditions or severe complications (e.g., HbA1c \> 8.0%, diabetic neuropathy/nephropathy/retinopathy, non-euthyroid state). * Cognitive impairment or dementia precluding questionnaire completion. * Klinefelter syndrome. * Literacy limitations preventing completion of self-report measures. * Additional control exclusion: Diagnosis or clinical suspicion of hypogonadism.
Where it's running
-
Bingöl University Faculty of Physical Therapy and Rehabilitation
Bingoel, Turkey (Türkiye) Recruiting -
Malatya Training and Research Hospital
Malatya, Turkey (Türkiye) Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Environmental and inflammatory links to metabolic and endocrine diseases
This project will see if combining environmental, genetic, and protein information can help predict early risk of diabetes, hypertension, and other metabolic or endocrine problems in community adults.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
Exercise Self-Efficacy, Body Composition, and Activity in Men with Low Testosterone
This study tests how confident men on testosterone therapy are at staying active and whether that confidence links body fat and lean mass with how much they exercise.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Hypertension: Does Education Help Patients Manage Blood Pressure Better?
This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.